• Mithra grants license to Chemical Dampe for commercialization of its vaginal contraceptive ring in Venezuela
  • Strengthening of the commercial presence in Latin and South America
  • Myring™ licenses granted to industry leaders in 36 countries, including the world's three largest markets

Liege, Belgium, 10 November 2020 - 7:30 CET - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that it has entered into a license and supply agreement (LSA) with Chemical Dampe for the commercialization of its hormonal contraceptive ring Myring™ in Venezuela. Based in Venezuela, Chemical Dampe builds alliances for the health of Venezuelans focused on women's health with advanced technology and high quality products, made inside and outside its borders.

Attachments

  • Original document
  • Permalink

Disclaimer

Mithra Pharmaceuticals SA published this content on 10 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2020 06:40:04 UTC